Bio Protocol (BIO) price action has broken out of a falling wedge, with the move confirmed by a sharp volume surge and a push to $0.0482.
The breakout ends an accumulation phase spanning from late January through late March. BIO now tests key Fibonacci retracement levels that will determine whether the rally extends.
The BIO/USDT daily chart shows a falling wedge that formed after BIO peaked near $0.0564 in early January 2026. Price produced lower highs and lower lows through February and March. The pattern compressed into a floor at $0.0157 on March 29.
The mid-April breakout arrived with the largest daily volume seen in months. A Fibonacci retracement from the January 6 high to the March 29 low places the 0.786 level at $0.0477. BIO tagged that level intraday before pulling back to the 0.5 Fib at $0.0360, up roughly 19% on the day.
Momentum indicators support the bullish structure. RSI is elevated but shows no bearish divergence. MACD is printing increasingly taller green bars, signaling growing buying pressure.
A correction to the 0.382 Fib at $0.0312 remains possible but would not invalidate the bullish case. Coinbase added BIO to its listing roadmap this year, broadening the token’s exchange visibility ahead of the breakout.
The 30-minute chart presents a more cautious near-term picture. A Fibonacci grid runs from the breakout origin near $0.0177 to the peak at $0.0482. BIO is currently trading around $0.0355, sitting between the 0.382 level at $0.0365 and the 0.5 level at $0.0329.
The nearest resistance sits at the 0.236 retracement near $0.0410. This zone rejected the price on the recent pullback. Reclaiming it would indicate short-term momentum has resumed.
The primary support is the golden 0.618 retracement at $0.0293. A break below that level would expose the 0.786 demand zone between $0.0210 and $0.0230.
RSI declined sharply after an extended stay in overbought territory. MACD is printing larger red bars, though a short-term bounce from current levels remains possible.
X user @Finora_EN offers a complementary one-hour view. The trader maintains a bullish bias as long as the $0.0304 to $0.0285 demand zone holds. That zone aligns with the 0.618 Fib level identified on the shorter timeframe.
The immediate upside target is $0.0335. A stronger continuation could send BIO back toward the $0.0482 prior high.
Earlier this year, an Upbit listing drove a 58% surge in BIO, showing how exchange catalysts can amplify moves quickly.
The trader identifies a potential entry in the $0.0285 to $0.0254 zone. Confirmation comes from a bullish engulfing candle or a strong reversal wick.
A one-hour close below $0.0254 would constitute a break of market structure. The bias would flip bearish in that scenario, with support at $0.0243 and $0.0191 next in line.
Binance Labs holds a stake in the project, adding institutional context to the recovery case. A bullish close above $0.0285 could set up a run back toward the $0.0482 peak.